Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brandon J Essink, MD
Meridian Clinical Research, Omaha (NE), USA
Principal Investigator - David J Seiden, MD
Broward Research Group (BRG), Hollywood (FL), USA
Principal Investigator - Deepen Patel, MD
Topstone Research, Toronto, Canada
Principal Investigator - Diane R Krieger, MD
Miami Research Associates (MRA), Miami (FL), USA
Principal Investigator - Ginette Girard, MD
Diex Research Sherbrooke, Sherbrooke, Canada
Principal Investigator - Guy Tellier, MD
Omnispec Clinical Research Inc, Mirabel, Canada
Principal Investigator - Gérald Vallières, MD
Manna Research, Lévis, Canada
Principal Investigator - Jamshid Saleh, MD
Paradigm Research, Redding (CA), USA
Principal Investigator - Luis Robles, MD
INC Research Toronto, Inc., Toronto, Canada
Principal Investigator - Marc Dionne, MD
Équipe de recherche en vaccination du CHU de Québec-Université Laval (CHU), Quebec, Quebec, Canada
Principal Investigator - Michael Libman, MD
McGill University Health Center - Vaccine Study Center (MUHC), Montreal, Canada
Principal Investigator - Paul Bradley, MD
Meridian Clinical Research, Savannah (GA), USA
Principal Investigator - Pierre Lachance, MD
Centre de Recherche St-Louis, Quebec, Quebec, Canada
Principal Investigator - Suchet R Patel, MD
Regional Clinical Research (RCR), Endwell (NY), USA
Principal Investigator - Trevor Wesson, MD
Diex Research Montreal, Montreal, Canada
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Inc Research Toronto
Toronto, Ontario, Canada
- Topstone Research
Toronto, Ontario, Canada
- Manna Research
Lévis, Quebec, Canada
- Omnispec Clinical Research
Mirabel, Quebec, Canada
- Diex Research Montreal
Montreal, Quebec, Canada
- Mcgill University Health Center - Vaccine Study Center (muhc)
Pierrefonds, Quebec, Canada
- Diex Research Sherbroooke
Sherbroooke, Quebec, Canada
- Centre de Recherche St-Louis
Québec, Canada
- Équipe de Recherche En Vaccination Du Chu de Québec-Université Laval (chu)
Québec, Canada
- Paradigm Research - Redding
Redding, California, United States
- Broward Research Group (brg)
Hollywood, Florida, United States
- Miami Research Associates (mra)
South Miami, Florida, United States
- Meridian Clinical Research - Savannah
Savannah, Georgia, United States
- Meridian Clinical Research - Omaha
Omaha, Nebraska, United States
- Regional Clinical Research (rcr)
Endwell, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2016
- Primary completion
- 31 Jul 2016
- Completion
- 31 Jan 2017
- Last update posted
- 25 Oct 2019
- Registered enrollment
- 1,001
- Registry id
- NCT02831751
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.